BRD4 and colitis: A series of in vitro and in vivo experiments were conducted, and it was found that Berberine repressed pyroptosis and alleviated intestinal mucosal barrier defects caused by colitis, by inhibiting activation of Wnt/β-catenin signaling pathway by regulating miR-103a-3p/BRD4 axis.